Logo image of MEGI

NYLI CBRE GBL INFR MGA TRM F (MEGI) Stock Price, Quote, News and Overview

NYSE:MEGI - New York Stock Exchange, Inc. - US56064Q1076 - Currency: USD

14.21  0 (0%)

After market: 14.64 +0.43 (+3.03%)

Fundamental Rating

2

MEGI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. MEGI has a bad profitability rating. Also its financial health evaluation is rather negative. MEGI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

MEGI had positive earnings in the past year.
MEGI had a positive operating cash flow in the past year.
MEGI Yearly Net Income VS EBIT VS OCF VS FCFMEGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

Industry RankSector Rank
ROA 9.62%
ROE 13.15%
ROIC 5.52%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MEGI Yearly ROA, ROE, ROICMEGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 -5 -10 -15 -20

1.3 Margins

Industry RankSector Rank
OM 72.28%
PM (TTM) 100%
GM 73.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MEGI Yearly Profit, Operating, Gross MarginsMEGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 100 -100

2

2. Health

2.1 Basic Checks

There is no outstanding debt for MEGI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MEGI Yearly Shares OutstandingMEGI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 10M 20M 30M 40M 50M
MEGI Yearly Total Debt VS Total AssetsMEGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.22, we must say that MEGI is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of MEGI is 2.45, which is a good value as it means it would take MEGI, 2.45 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.36 indicates that MEGI is not too dependend on debt financing.
Even though the debt/equity ratio score it not favorable for MEGI, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.45
Altman-Z 1.22
ROIC/WACCN/A
WACCN/A
MEGI Yearly LT Debt VS Equity VS FCFMEGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500M -500M 1B -1B

2.3 Liquidity

MEGI has a Current Ratio of 0.03. This is a bad value and indicates that MEGI is not financially healthy enough and could expect problems in meeting its short term obligations.
MEGI has a Quick Ratio of 0.03. This is a bad value and indicates that MEGI is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
MEGI Yearly Current Assets VS Current LiabilitesMEGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 100M 200M 300M 400M

2

3. Growth

3.1 Past

MEGI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 264.41%, which is quite impressive.
The Revenue has grown by 16.82% in the past year. This is quite good.
EPS 1Y (TTM)264.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%256.45%
Revenue 1Y (TTM)16.82%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%75.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MEGI Yearly Revenue VS EstimatesMEGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 20M 40M 60M 80M

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.32, which indicates a rather cheap valuation of MEGI.
MEGI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.91.
Industry RankSector Rank
PE 7.32
Fwd PE N/A
MEGI Price Earnings VS Forward Price EarningsMEGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.55
EV/EBITDA N/A
MEGI Per share dataMEGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.44%, MEGI is a good candidate for dividend investing.
MEGI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 10.44%

5.2 History

MEGI has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
MEGI Yearly Dividends per shareMEGI Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

77.23% of the earnings are spent on dividend by MEGI. This is not a sustainable payout ratio.
DP77.23%
EPS Next 2YN/A
EPS Next 3YN/A
MEGI Yearly Income VS Free CF VS DividendMEGI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 2024 0 -500M -1B
MEGI Dividend Payout.MEGI Dividend Payout, showing the Payout Ratio.MEGI Dividend Payout.PayoutRetained Earnings

NYLI CBRE GBL INFR MGA TRM F

NYSE:MEGI (7/29/2025, 8:04:01 PM)

After market: 14.64 +0.43 (+3.03%)

14.21

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners50.62%
Inst Owner Change0.65%
Ins Owners0.08%
Ins Owner Change1.67%
Market Cap739.63M
Analysts0
Price TargetN/A
Short Float %0.1%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield 10.44%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP77.23%
Div Incr Years2
Div Non Decr Years2
Ex-Date08-25 2025-08-25 (0.125)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.32
Fwd PE N/A
P/S 7.32
P/FCF 6.55
P/OCF 6.55
P/B 0.96
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)1.94
EY13.65%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.17
FCFY15.28%
OCF(TTM)2.17
OCFY15.28%
SpS1.94
BVpS14.76
TBVpS14.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.62%
ROE 13.15%
ROCE 9.51%
ROIC 5.52%
ROICexc 5.52%
ROICexgc 5.52%
OM 72.28%
PM (TTM) 100%
GM 73.27%
FCFM 111.88%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.45
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 111.88%
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 1.22
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)264.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%256.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.82%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%75.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y134.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.82%
OCF growth 3YN/A
OCF growth 5YN/A